Carregant...
Naftidrofuryl for intermittent claudication
BACKGROUND: Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive agents (Anatomic Therapeutic Chemical Classification (ATC) for medicines from the World Health Organisation class CO4A) is controvers...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2012
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075104/ https://ncbi.nlm.nih.gov/pubmed/23235580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001368.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|